274 related articles for article (PubMed ID: 33499238)
1. Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma.
Malchiodi ZX; Weiner LM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499238
[TBL] [Abstract][Full Text] [Related]
2. IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Van den Eynde A; Gehrcken L; Verhezen T; Lau HW; Hermans C; Lambrechts H; Flieswasser T; Quatannens D; Roex G; Zwaenepoel K; Marcq E; Joye P; Cardenas De La Hoz E; Deben C; Gasparini A; Montay-Gruel P; Le Compte M; Lion E; Lardon F; Van Laere S; Siozopoulou V; Campillo-Davo D; De Waele J; Pauwels P; Jacobs J; Smits E; Van Audenaerde JRM
J Hematol Oncol; 2024 Feb; 17(1):8. PubMed ID: 38331849
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironment.
Malchiodi ZX; Suter RK; Deshpande A; Peran I; Harris BT; Duttargi A; Chien MJ; Hariharan S; Wetherill L; Jablonski SA; Ho WJ; Fertig EJ; Weiner LM
bioRxiv; 2024 May; ():. PubMed ID: 38853982
[TBL] [Abstract][Full Text] [Related]
6. Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.
Lee YE; Go GY; Koh EY; Yoon HN; Seo M; Hong SM; Jeong JH; Kim JC; Cho D; Kim TS; Kim SC; Jun E; Jang M
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36849201
[TBL] [Abstract][Full Text] [Related]
7. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
Ijichi H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.
Yao L; Hou J; Wu X; Lu Y; Jin Z; Yu Z; Yu B; Li J; Yang Z; Li C; Yan M; Zhu Z; Liu B; Yan C; Su L
Redox Biol; 2023 Nov; 67():102923. PubMed ID: 37832398
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
Shinkawa T; Ohuchida K; Nakamura M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer.
Bryce AS; Dreyer SB; Froeling FEM; Chang DK
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358721
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines.
Gorchs L; Kaipe H
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203869
[TBL] [Abstract][Full Text] [Related]
12. The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma.
Lekan AA; Weiner LM
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339310
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor.
Inoue T; Adachi K; Kawana K; Taguchi A; Nagamatsu T; Fujimoto A; Tomio K; Yamashita A; Eguchi S; Nishida H; Nakamura H; Sato M; Yoshida M; Arimoto T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Int J Oncol; 2016 Oct; 49(4):1297-304. PubMed ID: 27499237
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer.
Geng X; Chen H; Zhao L; Hu J; Yang W; Li G; Cheng C; Zhao Z; Zhang T; Li L; Sun B
Front Cell Dev Biol; 2021; 9():655152. PubMed ID: 34336821
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
17. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
[TBL] [Abstract][Full Text] [Related]
18. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging.
Saúde-Conde R; Arçay Öztürk A; Stosic K; Azurmendi Senar O; Navez J; Bouchart C; Arsenijevic T; Flamen P; Van Laethem JL
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540204
[TBL] [Abstract][Full Text] [Related]
20. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
Front Oncol; 2020; 10():621937. PubMed ID: 33520728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
